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Iron is an essential cofactor in a number of critical biochemical reactions, and as such, its 
acquisition, storage, and metabolism is highly regulated in most organisms. The obligate 
intracellular bacterium, Chlamydia trachomatis experiences a developmental arrest when iron 
within the host is depleted. The nature of the iron starvation response in Chlamydia is relatively 
uncharacterized because of the likely inefficient method of iron depletion, which currently relies 
on the compound deferoxamine mesylate (DFO). Inefficient induction of the iron starvation 
response precludes the identification of iron-regulated genes. This report evaluated DFO with 
another iron chelator, 2,2′-bipyridyl (Bpdl) and presented a systematic comparison of the two 
across a range of criteria. We demonstrate that the membrane permeable Bpdl was superior to 
DFO in the inhibition of chlamydia development, the induction of aberrant morphology, and the 
induction of an iron starvation transcriptional response in both host and bacteria. Furthermore, 
iron starvation using Bpdl identified the periplasmic iron-binding protein-encoding ytgA gene 
as iron-responsive. Overall, the data present a compelling argument for the use of Bpdl, rather 
than DFO, in future iron starvation studies of chlamydia and other intracellular bacteria.
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existence of an iron-dependent gene expression – the best studied 
being dcrA, which encodes for a protein that has homology to the 
prototypical ferric uptake regulator (Fur) protein that regulate 
transcription of target genes. The exact function of this protein is 
not known, but it has been demonstrated by Wyllie and Raulston 
(2001) that it harbors a DNA-binding activity, and that it can bind 
the same palindromic sequence recognized by E. coli Fur. However, 
further attempts to identify the cis-acting sequence recognized by 
DcrA in Chlamydia was unsuccessful (Rau et al., 2005). Moreover, 
the lack of a genetically tractable system in Chlamydia has precluded 
the knock-out-mediated identification of the “DcrA-regulon.” This 
lack of further insight is not isolated to DcrA function in Chlamydia, 
but to the entire iron-dependent regulation of gene expression in 
general. We hypothesize that this paucity in our knowledge of this 
process could be attributed to a lack of an efficient iron starvation 
mechanism that overcomes the buffering ability of the cell in rela-
tion to the chlamydial organisms it harbors.
The only iron-chelating agent tested against members of the 
Chlamydiacea has been DFO, which binds Fe3+ well, but Fe2+ poorly 
(Martell and Smith, 1977). In addition, DFO is membrane imper-
meable, and thus its chelating ability is restricted to the extracel-
lular media, and perhaps the lumen of the endosomal vesicles 
(Lloyd et al., 1991; Cable and Lloyd, 1999; Persson et al., 2003; 
Glickstein et al., 2005). Of the published iron-restriction protocols 
for the Chlamydiacea, the overwhelming majority have utilized 
DFO with some  auxiliary mechanism for iron depletion, includ-
ing combination with cyclohexamide to block host up-regulation 
of the transferrin pathway (Raulston, 1997; Dill et al., 2009; Wehrl 
et al., 2004), or long-term pre-treatment of the host cells prior to 
infection (Al-Younes et al., 2001; Peters et al., 2005; Mukhopadhyay 
et al., 2006; Dill et al., 2009; Timms et al., 2009). Taken together, 
IntroductIon
As an obligate, intracellular pathogen, Chlamydia has an absolute 
requirement of the host for essential nutrients. The chlamydial 
requirement for the biometal, iron, has been well established 
(Raulston, 1997; Al-Younes et al., 2001). Iron is an essential nutrient 
for nearly all organisms, as it is utilized as an electron intermediate, 
cofactor, or prosthetic group in a number of conserved biochemical 
cellular processes. Its biological importance can be attributed to its 
role as a transition metal with the ability to accept and donate single 
electrons as it alternates between the ferric (Fe3+) and ferrous (Fe2+) 
oxidative states (Hentze et al., 2004). When deprived of iron via 
long-term treatment using the hydrophilic chelator, deferoxamine 
mesylate (DFO), Chlamydiae enter an alternative growth mode, 
termed persistence, which was defined as a “viable but non-culti-
vatable state” of growth (Beatty et al., 1994). Persistence induced 
by iron starvation is phenotypically similar to those induced by 
other well-characterized mediators, which include treatment of 
host cells with IFN-g (Beatty et al., 1993), amino acid limitation 
(Coles et al., 1993), and B-lactam antibiotic exposure (Matsumoto 
and Manire, 1970; Lambden et al., 2006), with all exhibiting the 
accumulation of aberrantly enlarged RBs within the inclusion and 
the loss of infectious progeny (Beatty et al., 1994; Hogan et al., 
2004; Mpiga and Ravaoarinoro, 2006; Wyrick, 2010). Noteworthy 
is the reversibility of this aberrant phenotype removal of the stress 
condition (Beatty et al., 1994).
Intracellular pathogens, like Chlamydia, are naturally buffered 
by the host cell from severe fluctuation of iron levels, given the 
ability of the host cell to maintain intracellular iron homeostasis. 
This raises the question of whether chlamydia requires, or even pos-
sesses iron-dependent regulatory mechanisms of gene expression. 
Analysis of the chlamydial genome reveals evidence to support the 
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permeabilized with MeOH and stained with convalescent human 
sera. Inclusions were visualized after secondary staining with Alexa-
594 conjugated mouse mAb anti-human IgG, and counted in five 
fields per well for the calculation of infectious titer.
Immunofluorescent AnAlysIs And mIcroscopy
Infected samples were fixed and permeabilized with MeOH, and 
immunolabeled with convalescent human sera. Alexa-594 conju-
gated mouse mAb anti-human IgG was used to visualize chlamydial 
morphology. Images were captured using Leica SP2 upright confo-
cal microscope. Bars represent 10 μm in each image.
nucleIc AcId prepArAtIon
Infected monolayers were trypsinized, pelleted, and resuspended in 
200 μl PBS for genomic DNA extraction, using the DNeasy Blood 
and Tissue Kit (QIAGEN) following the instructions of the manu-
facturer. Samples were eluted in a volume of 100 μl TE buffer.
RNA was extracted using Trizol Reagent (Invitrogen) using the 
instructions of the manufacturer for cells grown in a monolayer. 
Extracted RNA was DNAsed using Turbo DNase Kit (Applied 
Biosystems), precipitated in 80% ethanol overnight, dried, and 
resuspended in 20 μl nuclease free water (Applied Biosystems). 
RNA concentrations were measured using Nanodrop ND-1000 
spectrophotometer. Equal amounts of total RNA (2 μg) were 
converted to cDNA using Superscript III reverse transcriptase kit 
(Invitrogen) according to the instructions of the manufacturer. 
Reverse transcription was primed using random nonamers (New 
England Biolabs). cDNA mixture was diluted 1:8 with 10 mM Tris 
(pH 7.5), for a final volume of 160 μl and stored at −80°C.
reAl tIme QuAntItAtIve pcr (rt-qpcr)
Applied Biosystems 7300 Real time PCR System was used to carry 
out quantification of cDNA or gDNA sequences. Primers were 
designed using the Applied Biosystems Primer Express 3.0 Software 
and are listed in Table 1. Primer sets were tested for amplification 
these published protocols imply that DFO, by itself, may be an 
unsuitable or inefficient method for the iron starvation of the intra-
cellular pathogen, Chlamydia trachomatis. Moreover, the need for 
additional manipulations raises caveats in data interpretations. 
Therefore, we sought to identify an alternative means of starving 
Chlamydia of iron with minimal manipulation of the experimental 
system. We discovered that a single treatment at 100 μM dose at the 
time of infection with the compound, 2,2′-bipyridyl (Bpdl), which 
was previously identified as a membrane permeable iron-chelating 
agent capable of depleting the cytosolic labile iron pool (Breuer 
et al., 1995; Romeo et al., 2001), proved effective in inducing an 
iron starvation response in both the host cell and chlamydia. We 
present evidence that the compound Bpdl is more potent than DFO 
in inducing an iron-starved, persistent phenotype in C. trachomatis. 
Direct comparison with DFO also revealed a more robust and con-
sistent induction of the transcription of previously reported iron-
responsive genes. As final evidence of the superiority of Bpdl over 
DFO, ytgA, which encodes for an iron-binding periplasmic protein 
was found to be induced in iron-limiting conditions. Thus, we 
present an iron starvation protocol that requires minimal manipu-
lation, and possesses a potential broader applicability to Chlamydia 
and other intracellular bacteria.
methods
cell culture And chlAmydIAl InfectIons
Human endothelial HEp2 cells (CCL-23, ATCC) were grown 
at 37°C with 5% CO
2
 in Iscove’s Modified Dulbecco’s Medium 
(IMDM, Gibco) supplemented with 10% (v/v) fetal bovine serum 
(FBS), 20 mM l-glutamine (Gibco), and 10 μg/ml gentamicin. C. 
trachomatis UW-3/CX (serovar D) was originally obtained from Dr. 
Ted Hackstadt (Rocky Mountain Laboratory, NIAID), and propa-
gated as described (Caldwell et al., 1981).
For infections, HEp2 or HeLa cells were plated to 85–90% 
confluency in six-well tissue culture treated plates and incubated 
overnight. Next day, monolayers were treated with 45 μg/ml DEAE-
Dextran (Sigma) in HBSS for 10–15 min at 37°C prior to inocula-
tion with C. trachomatis. Plates were centrifuged at 1500 rpm at 4°C 
prior to a 30-min invasion step at 37°C. Inoculum was decanted, 
cells were washed with PBS, and cultured in complete IMDM (plus 
or minus iron-chelating agents).
Iron-chelAtIng Agents
Deferoxamine mesylate (Sigma, CAS: 138-14-7) was diluted to a 
stock concentration of 50 mM in ddH
2
O, filter sterilized and stored 
at 4°C for no more than 2 months. Bpdl (Sigma, CAS: 366-18-7) was 
diluted in ethanol to a stock concentration of 100 mM, aliquoted, 
and stored at −80°C.
QuAntIfIcAtIon of recoverAble InfectIous progeny
HEp2 cells were infected and treated as described. At 24 h post-
infection (p.i.; unless noted), infected monolayers were washed 
prior to physical dislodgement into 1 ml SPG buffer. Suspension 
was transferred to sterile eppendorf tubes containing three glass 
beads (3 mm, VWR) and vortexed for 60 s. Samples were stored at 
−80°C. For quantification, samples were diluted serially and appro-
priate doses were used to re-infect fresh, confluent monolayers 
of HEp2 cells in triplicate. The next day, samples were fixed and 
Table 1 | Primers used for quantitative PCR.
Gene Organism Fwd primer (5′–3′) Rev primer (5′–3′)
gapdh H. sapiens ctgctcctcctgttcgacagt accttccccatggtgtctga
tfr H. sapiens cattctttggacatgctcatctg tgatgaccgagatggtggaa
dmt1 H. sapiens ggagtactcttgttttagctttc ccagactgcaaatcggattca 
  gtaaa
fer-H H. sapiens tgaagctgcagaaccaacga cgctctcccagtcatcacagt
fer-L H. sapiens accgtttttgtggttagctcctt caggtcggtggaataattctga
euo Ctr serovar D gctgttcctgttacttcgcaaa aacatagatagcctgacgag 
   tcaca
omcB Ctr serovar D ccaaagcgaaagacaacacttct aaccggagcaacctctttacg
ahpC Ctr serovar D ccagttagctggacaaacca cgttccattgacgaggaat 
  ttccg tgcgt
devB Ctr serovar D acgaagatgtagaagctgg tgcggtatccatacgaaag 
  aagta atttg
ytgA Ctr serovar D ctcttgtgtttagcaggctgtttc tgcgattcatagacaagacat 
   agatg
tyrP-1 Ctr serovar D tcgcaggaacaaccattgg gtaacgtcgtaggcagga 
   atcc
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1986; Kato et al., 2007), resulting in the net increase in the levels of 
these transcripts. Conversely, ferritin heavy/light chain transcripts, 
which code for proteins that form a complex for the storage of 
excess iron, are normally degraded under the same low-iron condi-
tions (Kato et al., 2007). Based on previous reports of intracellular 
iron-chelation, we expected Bpdl to cause an iron-starved tran-
scriptional state of eukaryotic cells. Indeed, Bpdl treatment caused 
an elevated expression of tfr and dmt-1, which reached 5.2- and 3.5-
fold over the untreated sample, respectively (unpaired, one-tailed 
t-test, p = 0.0054 and 0.0065, respectively). Moreover, treatment 
with Bpdl elicited an approximate twofold reduction in ferritin 
heavy/light chain (fer-H/L) transcripts (p = 0.0255 and 0.0458, 
respectively). The ability for Bpdl to cause an “iron-starved” tran-
scriptional response from uninfected HEp2 cells, in a time frame 
where DFO could not, raised the possibility that Bpdl could induce 
a relatively robust iron starvation response and/or growth inhibi-
tion in C. trachomatis.
the effect of bIpyrIdyl on Acute C. traChomatis InfectIon
The observation that Bpdl was able to induce a greater iron star-
vation response from the host cell highly suggested that a similar 
response could be elicited from intracellular chlamydiae. Therefore 
we tested both Bpdl and DFO for effects on chlamydial develop-
ment and inclusion morphology, with an emphasis on the simplest 
possible iron starvation protocol, which involves a single treatment 
at the time of infection. In order to test the effect of Bpdl on C. 
trachomatis development, a dose-response analysis of recoverable 
inclusion forming units (IFU) was performed (Figure 3). HEp2 
cells were infected with C. trachomatis serovar D at an MOI of 
0.5 prior to culture in normal (iron-replete) medium containing 
various doses of DFO or Bpdl for 24 h. Infectious progeny were 
harvested and replated onto fresh monolayers for quantification. 
C. trachomatis growing in iron-replete medium consistently pro-
duced over 107 IFUs/ml. No significant inhibition of recoverable 
IFUs was observed upon addition of low doses (25 or 50 μM) 
of Bpdl to the culture medium. The same doses of DFO (25 
and 50 μM) each caused an approximate 70% decrease in IFU 
output that was significantly lower than the untreated control 
(unpaired, two-tailed t-test; p = 0.0046 and p = 0.0072, respec-
tively). However, at concentrations of 100 and 250 μM, Bpdl was 
more effective relative to the untreated sample. At 100 μM, Bpdl 
caused a 2.5-log reduction of recoverable IFUs from the untreated 
control (p = 0.0001). Moreover, inhibition of infectious progeny 
efficiency against gDNA extracted from purified EBs, and for the 
generation of specific products using 7300 system post-run Tm 
function. Samples were assayed in triplicate wells of a 96 well plate; 
each reaction contained 5 μl DNA (complimentary or genomic), 
25 μl 2X SYBR green master mix (Applied Biosystems), 0.45 pmol 
forward and reverse primers, and 19.8 μl RNase/DNase free water 
(Applied Biosystems). No RT and no template controls were per-
formed regularly.
Relative expression of eukaryotic iron-responsive transcripts 
was quantified using the Pfaffl method (2∆∆Ct method; Pfaffl, 2001). 
Target iron-responsive transcripts were normalized to gapdh 
transcript levels and calibrated to the untreated sample. Absolute 
expression of Chlamydia transcripts was quantified using seri-
ally diluted C. trachomatis genomic DNA, which was extracted 
from EBs, as a standard. Levels of mRNA were normalized to the 
number of Chlamydia-specific genomes, which were derived from 
parallel samples.
grAphs And stAtIstIcAl AnAlysIs
Generation of all graphs and statistical tests were performed in 
GraphPad Prism v5.0 Software. Specific statistical tests are described 
in the Section “Results” and figure legends. Unless noted, graphs 
represent mean averages ± SD.
results
eukAryotIc Iron-responsIve trAnscrIptIon After Iron-
chelAtor treAtment
Intracellular chlamydia are naturally protected from severe fluc-
tuations of extracellular environmental conditions, and thus 
eliciting a response for the bacterium would first require that the 
host cell be affected. Two different iron chelators, DFO and Bpdl 
(shown in Figure 1) were evaluated for their ability to induce an 
iron response from the host cell, with the underlying assumption 
that iron starvation of the host would lead to iron starvation of 
intracellular chlamydiae. To assess the level of host iron starvation, 
we chose to examine the differential regulation of a handful of 
iron-related transcripts that are known to respond to changes in 
iron levels. We utilized the mRNA levels of specific iron-responsive 
transcripts from uninfected HEp2 cells that had been treated with 
DFO or Bpdl for 10 h (Figure 2). The mRNA of two genes cod-
ing for iron-acquisitional proteins, transferrin receptor (TfR) and 
divalent metal transport protein 1 (DMT1) are normally stabilized 
under conditions of low cytoplasmic iron availability (Rao et al., 
FiGuRe 1 | Chemical structure of iron-chelating agents. Deferoxamine mesylate (DFO) is a hydrophilic compound with a high affinity for ferric iron (Martell and 
Smith, 1977). It binds ferric iron in a 1:1 (hexadentate) complex (Gaeta and Hider, 2005). 2,2′-bipyridyl (Bpdl) is a membrane permeable compound with similar 
moderate affinities for Fe2+ and Fe3+ (Smith and Martell, 1975), and binds both species of these molecules in a 3:1 molar ratio (bidentate; Gaeta and Hider, 2005).
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control (p = 0.0002). However, this result was highly variable with 
a percent recovery that ranged from 0 (complete arrest) to 12.5% 
of the untreated control. Compared directly, treatment with Bpdl 
was 26-fold more effective than DFO in limiting the development 
was highly  reproducible with the percent recovery ranging from 
just 0 to 0.33% of the untreated control over three independent 
experiments. At 100 μM concentration administered at the time 
of infection, DFO yielded a 95% reduction from the untreated 
FiGuRe 2 | Bipyridyl treatment modulates eukaryotic iron-responsive 
transcription. Human epithelial HEp2 cells were incubated in complete medium 
containing 100 μM DFO or Bpdl for 10 h before select transcript levels were 
measured via RT-qPCR. Reported iron-responsive genes, transferrin receptor (TfR) 
and divalent metal transporter 1 (DMT1), and iron-repressed genes, ferritin heavy 
and light chain (Fer-H/L) were normalized to endogenous glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) mRNA levels and then calibrated to the 
untreated control (∆∆Ct method; Pfaffl, 2001). The y-axis presents the natural log of 
the target gene relative expression. Bars represent the natural log of mean relative 
expressions ± SD in one representative experiment containing two biological 
replicates per treatment, each assayed in triplicate. Experiment was performed 
independently two times and obtained similar transcriptional profiles in each case 
(i.e., total of four biological replicates were observed). Statistical significance from 
the untreated was determined by unpaired, one-tailed t-test (*p < 0.05, **p < 0.01).
FiGuRe 3 | infectious progeny of C. trachomatis samples cultured with 
iron-chelating agents. Various concentrations of DFO (black bars) or Bpdl (white 
bars) were included in the culture medium added immediately post-chlamydial 
invasion. Infectious titers were quantified after 24 h of treatment and presented 
as inclusion forming units (IFU) per milliliter of inoculum (y-axis). Graph represents 
the mean ± SD derived from at least two independent experiments, assayed in 
triplicate. Statistical significance determined with unpaired, two-tailed t-test in 
conjunction with F-test (*p < 0.05, **p < 0.01, ***p < 0.001). Asterisks without 
brackets represent comparison to the untreated control; brackets indicate the 
comparison of DFO to Bpdl at the same concentration.
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of the experimental system. Under such conditions, Bpdl appeared 
to be more efficient in initiating and maintaining a developmental 
arrest in C. trachomatis.
chlAmydIAl vIAbIlIty upon bIpyrIdyl treAtment
The term “persistence,” refers to the ability of non-cultivatable 
chlamydiae to re-enter the acute life-cycle and cause disease upon 
the removal of the condition of stress. We chose to examine the 
reversibility of the persistent phenotype of chlamydia exposed to 
Bpdl in two ways. First, persistent Chlamydiae often exhibit con-
tinued genomic replication, albeit at a reduced rate, despite a lack 
of re-differentiation into the infectious EB form (Belland et al., 
2003; Lambden et al., 2006). Therefore Chlamydia-specific genomic 
DNA (gDNA) was monitored longitudinally during iron-chelation 
treatment using real time qPCR. Incubation with DFO and Bpdl 
(100 μM) retarded chlamydial DNA replication, compared to the 
untreated control. However, consistent with the recoverable IFU 
and IFA data, Bpdl treatment caused an even greater growth defect 
than that of DFO-treatment (Figure 5A). During the exponen-
tial phase of growth (between 12 and 24 h post-infection), Bpdl-
treated C. trachomatis gDNA doubled once every ∼5.5 h, compared 
to approximately each 2.5 and 3.3 h for untreated and DFO-treated 
cultures, respectively, over the same time period. Importantly, the 
number of genomes increased during each time period tested 
of infectious progeny (p = 0.0408). While both compounds caused 
similar reduction in recoverable IFU at 250 μM, some cells were 
lost indicating possible cytotoxicity (data not shown). Therefore, 
100 μM was deemed a suitable concentration for both iron-chelat-
ing agents for subsequent experiments.
As the loss of recoverable infectious progeny due to develop-
mental arrest is a hallmark of the chlamydial persistent phenotype 
(Beatty et al., 1994), we examined C. trachomatis samples cultured 
with Bpdl for another characteristic of persistence, the formation 
of aberrantly enlarged RBs. Infected cell cultures were treated 
for 24 or 48 h with 100 μM concentrations of Bpdl or DFO and 
visualized by immunofluorescent confocal microscopy (Figure 4). 
Compared to the untreated control, culture with both DFO and 
Bpdl (100 μM, administered at the time of infection) caused a 
qualitatively similar reduction in the size of chlamydial inclusions 
at 24 h p.i. (Figures 4A–C). Enlarged, aberrant RBs, character-
istic of the persistent phenotype, were only observed after 48 h 
of culture with Bpdl (Figure 4F). Interestingly, the same 48-h 
length of treatment with DFO (Figure 4E) yielded a population 
of chlamydial inclusions, the majority of which resembled that of 
the untreated, 24-h p.i. sample (Figure 4A), suggesting that DFO 
may not be suitable for time-points of this length. It should be noted 
that growth media was neither replaced nor additional chelators 
added, consistent with our intention of minimizing manipulation 
FiGuRe 4 | Chlamydial morphology after long-term incubation with 
inhibitory doses of Deferoxamine or Bipyridyl. C. trachomatis-infected cell 
cultures were incubated with 100 μM DFO (B, e) or Bpdl (C,F) in conjunction 
with untreated controls (A,D). Images from the top panel row (A–C) were fixed 
after 24 h p.i. and images from the bottom panel row (D–F) were fixed after 48 h 
p.i. Samples were stained immunofluorescently using convalescent human 
sera. Aberrant RB morphology and a lack of EB particles within the inclusional 
lumen was only observed upon 48 h of Bpdl treatment (F). Samples treated 
with DFO for 48 h (e) exhibited similar characteristics of untreated 24 h growth 
(A). Images were captured using Leica Confocal microscope. Bars represent 
10 μM in each panel/inset. Images selected represent the overall trends 
observed in four independent experiments.
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ExogEnous iron abrogatEs chlamydial inhibition causEd by 
bipyridyl and dEfEroxaminE
To ensure that effects elicited by culture with Bpdl resulted from 
the restriction of iron, an iron-titration experiment was performed, 
in which increasing concentrations of Fe3+ or Fe2+ were added to an 
inhibitory dose (100 μM) of the two iron-chelating agents, prior to 
their incubation with infected cell cultures. To confirm the bind-
ing capabilities of Bpdl, we utilized species of both ferric (FeCl
3
) 
and ferrous (FeSO
4
) oxidative states of iron. Based on reported 
affinities (Smith and Martell, 1975; Martell and Smith, 1977), it was 
not surprising that both Bpdl and DFO-mediated inhibition was 
abrogated by the addition of exogenous ferric chloride (Figure 6A). 
In contrast, the addition of ferrous sulfate was not able to rescue 
DFO-mediated inhibition of recoverable IFU output (Figure 6B), 
which was expected, based on its reported specific affinity for fer-
ric iron (Martell and Smith, 1977). The lack of recovery exhibited 
by ferrous iron supplementation illustrated the inability of DFO 
to bind the divalent metal in the extracellular medium, coupled 
with the inability of the host cell to efficiently import the supple-
mented ferrous iron. The end result was the unaltered sequestra-
tion of ferric iron in the extracellular media, which, of course, is 
the main source of host cell iron acquisition. This result was not 
the case for Bpdl-mediated inhibition, as recoverable IFU output 
was completely reversed at 20 μM of FeSO
4
, which was the lowest 
dose tested, reflecting its ability to bind the divalent oxidation state 
for Bpdl-cultured samples, indicating active genomic replica-
tion, and thus viable organisms, despite the lack of infectious EB 
re-differentiation.
Reactivation of developmentally arrested chlamydiae upon 
removal of the chelator was monitored using recoverable IFUs 
as a measure of viability. Infected HEp2 cells were incubated with 
Bpdl for 18 or 24 h, and then “reactivated” by the replacement of 
Bpdl-supplemented media with normal (iron-replete) medium 
for another 18 to 24 h of incubation. The infectious titer of each 
sample was quantified and compared to samples incubated with 
Bpdl for the entire course of infection (Figure 5B). A near com-
plete arrest of infectious EB re-differentiation was observed at 
24, 36, and 48 h of continuous treatment with Bpdl, which was 
consistent with the aberrant morphology observed by immun-
ofluorescent analysis at 48 h p.i. (Figure 4F). In contrast, “reac-
tivated” samples exhibited an increase in recoverable infectious 
progeny of 2–3 logs over continuously treated samples. Although 
reactivated chlamydial samples were not completely rescued to 
the untreated output levels, a majority of chlamydiae were able 
to re-enter the acute life-cycle and re-differentiate into the infec-
tious EB form.
Figure 5 | Viability of C. trachomatis cultured with Bipyridyl. (A) 
Chlamydia-specific DNA was quantified via RT-qPCR from total genomic DNA 
extracted each 6 h. The numbers of chlamydial genomes (y-axis) were 
extrapolated from a standard curve of genomic DNA obtained from purified 
chlamydial EBs. Data points represent the mean ± SD of two independent 
experiments, which were representative of greater than five independent 
time course experiments. (B) Bpdl-cultured C. trachomatis were reactivated 
by washing and incubation with normal, iron-replete medium (“18 + 18” and 
“24 + 24”) and compared to cultures treated with Bpdl throughout the entire 
experiment (“24,” “36,” “48”). C. trachomatis treated with Bpdl for 18 and 
24 h were still viable when cultured with normal media. Graph represents data 
combined from two independent experiments, each assayed in triplicate. Bars 
represent mean ± SD.
Figure 6 | The effect of iron on iron-chelator mediated recoverable iFu 
inhibition. Increasing concentrations of ferric (A) or ferrous (B) iron were 
used to titrate out the inhibition of C. trachomatis infectious progeny caused 
by treatment with (100 μM) Bpdl or DFO. Exogenous iron was added to 
medium containing chelators immediately prior to its use in culture. Samples 
were harvested at 24 h p.i. for infectious titer quantification. Bars represent 
the mean ± SD of one experiment representative of two independent trials in 
which similar trends were obtained.
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known to be induced under iron-limiting conditions. We moni-
tored the expression of known molecular markers of persistence 
– the continued expression of the early gene euo (Belland et al., 
2003; Ouellette et al., 2006; Timms et al., 2009) and the failure to 
induce transcription of the late gene omcB (Iliffe-Lee and McClarty, 
2000; Belland et al., 2003; Ouellette et al., 2006; Timms et al., 2009). 
Therefore the expression of persistence markers, euo and omcB, was 
measured longitudinally from DFO, Bpdl, and untreated cultures 
via RT-qPCR and normalized by the genome copy number derived 
of the metal. Taken together, the addition of exogenous ferric and 
ferrous iron abrogated the inhibitory effects of Bpdl, while only 
ferric iron restored IFU yield in DFO-treated samples.
the effect of bIpyrIdyl treAtment on chlAmydIAl 
trAnscrIptIon
Having validated Bpdl treatment as an efficient mediator of the 
chlamydial persistent response, we decided to test its effects on 
chlamydial transcription of genes associated with persistence or 
FiGuRe 7 | Time course analysis of selected transcript expression of C. 
trachomatis. Samples were cultured in normal iron-replete medium (--•--), or in 
conjunction with deferoxamine (----) or bipyridyl (--∆--). Total RNA was extracted 
longitudinally and reverse transcribed to cDNA for quantification using specific 
primer sets (Table 1). cDNA levels were adjusted to reflect the number of 
chlamydial organisms by using the number of chlamydial genomes determined 
from parallel samples. (A) Transcripts whose expression were altered under 
multiple models of persistence (Iliffe-Lee and McClarty, 2000; Belland et al., 
2003; Ouellette et al., 2006; Timms et al., 2009). (B) Transcripts from C. 
trachomatis whose expression were altered under iron-restriction. (C) ytgA, a 
transcript whose expression was hypothesized to be responsive to fluctuations 
in iron availability, along with tyrP1 whose transcription was altered under IFN-g 
treatment, but not iron-restriction in C. pneumoniae (Timms et al., 2009). 
Statistical significance relative to the untreated control was determined using 
two-tailed t-test (Bpdl-treated samples: *p < 0.05, **p < 0.01, ***p < 0.001; 
DFO-treated samples: ##p < 0.01).
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from a parallel sample. As expected, appreciable omcB expression 
was not observed until 18 to 24 h p.i. in the untreated control, which 
correlates to the onset of EB re-differentiation for C. trachomatis. 
Alternatively, the expression of euo in the same samples increased 
during the earliest time-points measured and then decreased to 
near absent levels during the late stages of infection (Figure 7A). 
Culture with 100 μM DFO from the time of infection did not alter 
either of these transcriptional profiles, suggesting that a persistent 
phenotype could not be induced efficiently by this iron chelator 
when administered at the time of infection. In contrast, incuba-
tion with Bpdl caused the extended repression of omcB transcript 
expression throughout the entire time course. Concomitantly, 
expression of euo remained elevated until the late stages of infec-
tion. The altered expression of these two genes indicated that cul-
ture with Bpdl (100 μM), from the time of infection, elicited a 
persistent chlamydial phenotype.
We sought to validate the Bpdl model by monitoring its effects 
on the transcription of two previously reported chlamydial iron-
responsive genes, ahpC and devB (Dill et al., 2009), in parallel with 
untreated and DFO-treated cultures. When included immediately 
post-invasion, a 100-μM concentration of DFO, noticeable increases 
in the levels of devB transcript were only observed at 24 (2.6-fold) 
and 30 (2.5-fold) h p.i. (unpaired, two-tailed t-test; p = 0.0740, 
p = 0.0023, respectively), while no differential transcription of ahpC 
was observed (Figure 7B). In contrast, culture with Bpdl caused sta-
tistically significant elevation over the untreated control at multiple 
time-points of both ahpC and devB (Figure 7B), with a statistically 
significant increase observed as early as 6 h post-treatment for devB. 
Maximum differential expression occurred at 24 h p.i. for ahpC, 
and reached 3.1-fold over the untreated levels (p = 0.0008). For 
devB, maximum differential expression reached 5.6-fold at 30 h p.i. 
(p = 0.0009). Taken together, treatment with Bpdl caused a more 
robust induction ahpC and devB than treatment with DFO. Not 
only was the altered expression more pronounced, it also lasted 
longer, suggesting significant and sustained iron-deprivation.
We also analyzed the expression of ytgA. YtgA, a proposed peri-
plasmic iron-binding protein, was reported to be iron-responsive 
at the protein level upon long-term treatment with DFO (Miller 
et al., 2009), yet its differential expression at the transcript level 
has never been shown, and thus served as an excellent candidate to 
further evaluate the efficiency of iron starvation mediated by Bpdl. 
Using the Bpdl model, expression of ytgA was clearly elevated after 
24 and 30 h p.i. (unpaired, two-tailed t-test; p = 0.0083, p = 0.0433, 
respectively; Figure 7C), providing a mechanism for the elevated 
protein expression previously observed (Miller et al., 2009). Thus, 
the greater effectiveness of the new iron starvation method was 
validated by the discovery of ytgA being an iron-responsive gene 
at the level of transcription.
To ensure that the up-regulation of ahpC, devB, and ytgA were 
specific to iron-limitation, the expression of tyrP-1, which codes for 
an aromatic amino acid transporter, was monitored. Its transcript 
expression in C. pneumoniae was differentially expressed under 
persistence mediated by IFN-g treatment, but not iron-restriction 
(Timms et al., 2009). IFN-g is thought to induce expression of 
the host enzyme, indoleamine dioxygenase (IDO), which effec-
tively limits the available amount of tryptophan within the cell 
(Wood et al., 2004). Therefore its elevated expression under IFN-g 
 mediated persistence presumably functions to increase acquisition 
of the limited amino acid. Because Timms et al. (2009) reported 
that it was not differentially expressed under conditions of low-iron 
availability, its transcript expression was monitored to distinguish 
the effects of Bpdl-mediated iron starvation from general persist-
ence. As expected, transcription of tyrP1 was not altered under 
Bpdl treatment at any time-point tested (Figure 7C). The fact that 
this mid-stage gene was not differentially expressed under Bpdl-
mediated persistence indicated that the elevated transcription pub-
lished in this study was specific to iron-restriction. Taken together, 
the data indicate collectively that a single-dose Bpdl treatment is an 
efficient iron-restriction model for the growth of C. trachomatis, 
and is able to elicit a more uniform, and consequently, a more 
robust response from Chlamydiae than DFO under identical treat-
ment conditions.
dIscussIon
We present a re-evaluation of the currently available iron starvation 
protocol for intracellular bacteria by directly comparing DFO and 
Bpdl for their abilities to induce iron starvation-related phenotypes 
in the obligate intracellular pathogen C. trachomatis. The goal was 
to identify an alternative means of starving Chlamydia of iron with 
minimal manipulations, such as pre-starving the host cell, or pre-
venting it from synthesizing proteins involved in iron acquisition. 
Our motivation for simplifying iron starvation of Chlamydia by 
excluding such manipulations was to minimize potential contribu-
tory factors that may confound data interpretation. To this end, 
we identified Bpdl to be a better iron chelator than DFO under 
single-treatment experimental conditions. In a number of crite-
ria, specifically IFU yield, aberrant RB formation, and transcrip-
tional modulation of previously reported persistence indicating 
genes, Bpdl was consistently more potent than DFO. Moreover, 
the increased differential transcription of iron-responsive genes, 
ahpC and devB, in the Bpdl protocol relative to the DFO starvation 
method validated the alternative iron starvation system. Finally, the 
Bpdl model allowed the novel observation that ytgA, which codes 
for an iron-binding periplasmic protein thought to be involved in 
iron acquisition/transport into Chlamydia, is iron-responsive at the 
transcript level. The use of this Bpdl model could allow additional 
insights into the global iron-restricted regulon of C. trachomatis.
Our study was initiated due to the inefficient ability of DFO to 
elicit a uniform, persistent phenotype of C. trachomatis for analysis 
of differential gene expression. We hypothesized that DFO, which 
is not membrane permeable and can only bind ferric iron, could 
only be efficient in the iron-restriction of the obligate intracel-
lular pathogen if the only chlamydial source of iron was the direct 
acquisition of ferric iron as it entered the host cell via the transfer-
rin pathway. On the other hand, if Chlamydia were able to acquire 
iron from another source, e.g., from the cytosolic labile iron pool 
or the slow recycling pathway (Ouellette and Carabeo, 2010), then 
use of DFO would require longer treatment to deplete intracel-
lular iron stores. In the literature, DFO has rarely been used with-
out auxiliary steps or methods for iron-restriction. For instance, 
the combination of DFO with cyclohexamide (which is a general 
eukaryotic protein synthesis inhibitor) has been employed to pre-
vent the host cell up-regulation of the transferrin iron-acquisition 
pathway (Raulston, 1997; Wehrl et al., 2004; Dill et al., 2009). Yet the 
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initially the compound of choice. However, its structural similarity 
to a family of molecules known to inhibit the function of type III 
secretion apparatus in a number of bacterial pathogens precluded 
accurate interpretations of its growth effects on chlamydia. Indeed, 
we have observed the inhibition of the cytosolic translocation of the 
Salmonella effector PipB2 in infected cells treated with SIH for 8 h 
(Thompson and Carabeo, unpublished data), and hence, investiga-
tions of the functions of type III secretion in Chlamydia using these 
SIH-related compounds must be taken with caution.
In summary, the detailed characterization of DFO and Bpdl with 
regards to their effects on C. trachomatis when supplemented at 
the time of infection, revealed the superiority of Bpdl. Moreover, 
this model is easier to apply and eliminated many of the caveats 
of other DFO- based iron-restriction protocols. As such, efforts to 
identify bona fide primary iron-responsive regulons may now be 
compatible with microarray approaches, given the availability of a 
faster acting iron chelator that, in addition to the extracellular iron 
pool, targets the pools in the DFO-inaccessible cytosolic, organellar, 
and chlamydial environment.
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